Bridging mechanism and clinic: unlocking the full potential of oncolytic virus-based immunotherapy
Abstract Oncolytic viruses (OVs) have emerged as a distinctive class of cancer therapeutics capable of coupling direct tumor cell lysis with broad immune activation, thereby reshaping antitumor immunity beyond the capacities of conventional modalities. Despite substantial progress, the clinical tran...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMC
2026-03-01
|
| Σειρά: | Molecular Cancer |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1186/s12943-026-02651-4 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|